BIOTECHNOLOGY DEVELOPMENT FUND II LP 4
4 · BIOFORM MEDICAL INC · Filed Jan 21, 2010
Insider Transaction Report
Form 4
BIOASIA MANGEMENT LLC
10% Owner
Transactions
- Sale
Common Stock
2010-01-19$5.51/sh−420,054$2,315,380→ 2,558,713 total(indirect: By Biotechnology Development Fund II, L.P.)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.51 to $5.53. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The reported securities are owned directly by Biotechnology Development Fund II, L.P. and indirectly by BioAsia Management, LLC, as general partner of Biotechnology Development Fund II, L.P. BioAsia Management, LLC disclaims beneficial ownership of these securities except to the extent of its pecuniary interest therein.